Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) was the recipient of a large increase in short interest in November. As of November 15th, there was short interest totalling 1,654,500 shares, an increase of 6.0% from the October 31st total of 1,560,500 shares. Based on an average trading volume of 4,053,100 shares, the days-to-cover ratio is currently 0.4 days.

Elite Pharmaceuticals Price Performance

Shares of OTCMKTS ELTP opened at $0.60 on Wednesday. Elite Pharmaceuticals has a fifty-two week low of $0.12 and a fifty-two week high of $0.75. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.42 and a current ratio of 3.52. The company has a market cap of $644.17 million, a PE ratio of -60.30 and a beta of 0.25. The business has a 50-day simple moving average of $0.51 and a two-hundred day simple moving average of $0.32.

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.